Phibro Animal Health
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Phibro Animal Health Corporation operates as a global entity focused on the research, production, and supply of a wide array of animal health and mineral nutrition solutions. While serving a global cl...
Latest News
10 days ago · seekingalpha.com
Phibro Animal Health Corporation (PAHC) Q1 2027 Earnings Call TranscriptPhibro Animal Health Corporation ( PAHC ) Q1 2027 Earnings Call November 5, 2026 9:00 AM EST Company Participants Glenn David - Chief Financial Officer Patrick Rodriguez - Vice President of Finance & Treasurer Daniel Bendheim - CEO, President & Director Larry Miller - Chief Operating Officer Conference Call Participants Ekaterina Knyazkova - JPMorgan Chase & Co, Research Division Curtis Moiles - BNP Paribas, Research Division Presentation Operator Hello, everyone. Thank you for joining us, and welcome to Phibro Animal Health Corporation to host webcast and conference call on first quarter results.
12 days ago · zacks.com
Phibro (PAHC) Reports Q1 Earnings: What Key Metrics Have to SayAlthough the revenue and EPS for Phibro (PAHC) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
12 days ago · businesswire.com
Phibro Animal Health Corporation Reports First Quarter Results, Maintains Financial GuidanceTEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its first quarter ended September 30, 2026 and maintained its financial guidance for the year ending June 30, 2027. Highlights for the three months ended September 30, 2026 (compared to the three months ended September 30, 2025) Net sales of $386.8 million, an increase of $22.9 million, or 6% Net income of $29.5 million, an increase of $3.0 million, o.
13 days ago · businesswire.com
Phibro Animal Health Corporation Declares Quarterly DividendTEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on December 16, 2026, to stockholders of record at the close of business on November 25, 2026. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner w.
19 days ago · businesswire.com
Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter ResultsTEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its first quarter financial results on Wednesday, November 4, 2026, after the market closes. Phibro management will host a conference call and webcast on Thursday, November 5, 2026, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (83.
25 days ago · zacks.com
Will Phibro (PAHC) Beat Estimates Again in Its Next Earnings Report?Phibro (PAHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
27 days ago · zacks.com
PAHC or SYK: Which Is the Better Value Stock Right Now?Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now?
1 month ago · zacks.com
PAHC vs. HAE: Which Stock Is the Better Value Option?Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Haemonetics (HAE). But which of these two stocks presents investors with the better value opportunity right now?
2 months ago · zacks.com
Best Momentum Stocks to Buy for September 21stSEI, SDRL and PAHC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 21st, 2026.
2 months ago · zacks.com
PAHC vs. HAE: Which Stock Should Value Investors Buy Now?Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Haemonetics (HAE). But which of these two stocks presents investors with the better value opportunity right now?
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove PAHC